Nanosonics Limited (FRA:OQS)

Market Cap	658.63M -13.9%
Revenue (ttm)	117.75M +12.7%
Net Income	11.68M +24.1%
EPS	0.04 +24.7%
Shares Out	n/a
PE Ratio	56.39
Forward PE	54.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.180
Previous Close	2.120
Day's Range	2.180 - 2.180
52-Week Range	1.910 - 2.780
Beta	n/a
RSI	49.57
Earnings Date	Feb 23, 2026

About Nanosonics

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabi...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 470
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OQS

Financial Performance

In fiscal year 2025, Nanosonics's revenue was 198.63 million, an increase of 16.83% compared to the previous year's 170.01 million. Earnings were 20.68 million, an increase of 59.39%.

Financial numbers in AUD